| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $189.7M | -9.2% |
| Cost of Revenue | $199.8M | +3.0% |
| Gross Profit | -$10.1M | -166.9% |
| R&D Expense | $85.1M | -12.2% |
| SG&A Expense | $66.3M | -20.2% |
| Operating Income | -$323.2M | +55.8% |
| Pre-tax Income | -$326.4M | +56.0% |
| Income Tax | -$3.1M | -107.3% |
| Net Income | -$323.3M | +56.3% |
| EPS (Basic) | -$1.00 | +57.4% |
| EPS (Diluted) | -$1.00 | +57.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.8M | +9.9% |
| Short-term Investments | $625K | -99.4% |
| Accounts Receivable | $37.7M | -2.1% |
| Inventory | $82.6M | -9.9% |
| Current Assets | $216.1M | -35.8% |
| Total Assets | $458.0M | -39.3% |
| Current Liabilities | $70.1M | -15.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.0M | +36.7% |
| Capital Expenditures | $2.8M | -76.0% |
| Investing Cash Flow | $117.3M | +43.8% |
| Financing Cash Flow | $534K | -99.5% |
| Free Cash Flow | -$117.8M | +39.0% |
| Total Liabilities |
| $216.3M |
| -4.6% |
| Stockholders' Equity | $241.7M | -54.2% |